Artemis Medicare Services Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook

The Artemis Medicare Services share price forecast comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 310.25 on NSE as of 9 October 2026, 18.1% below its 52-week high of Rs 378.80, after the company reported net profit of Rs 103.72 crore for FY26.

This Artemis Medicare Services stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.

Click Here – Get Free Investment Predictions

Artemis Medicare Services Share Price Today and Key Data

The Artemis Medicare Services share price today is Rs 310.25 on NSE, up 0.58% on the day. The market capitalisation stands at Rs 4,883 crore. Over the past year the price has risen 32.5% from Rs 234.16. Every Artemis Medicare Services stock forecast figure below starts from this price.

Metric	Value
Company	Artemis Medicare Services (ARTEMISMED)
Current Price	Rs 310.25
52-Week High	Rs 378.80 (25 September 2026)
52-Week Low	Rs 203.35 (30 March 2026)
Market Cap	Rs 4,883 crore
PE Ratio	42.84
Industry PE	62.79
PB Ratio	5.64
EPS (TTM)	Rs 7.20
Return on Equity	11.09%
Debt to Equity	0.28
Dividend Yield	0.15%
Book Value per Share	Rs 54.69

What Is the Artemis Medicare Services Share Price Prediction for 2027?

The Artemis Medicare Services share price prediction for 2027 is a conservative case of Rs 357, a base case of Rs 372 and a bull case of Rs 446. Against Rs 310.25, these imply 15.1% upside, 19.9% upside and 43.8% upside. They are model scenarios built from reported EPS growth, not broker targets.

Scenario	EPS Growth Basis	EPS Estimate	PE Multiple	Implied Value	Upside vs Current Price
Conservative Case	Lower of FY26 growth (23.5%) and 4-year CAGR (30.1%) (capped at 15%)	Rs 8.28 (+15.0%)	Unchanged from today (price to EPS ratio kept constant)	Rs 357	+15.1%
Base Case	Average of the two (capped at 20%)	Rs 8.64 (+20.0%)	Unchanged from today (price to EPS ratio kept constant)	Rs 372	+19.9%
Bull Case	Higher of the two (capped at 25%)	Rs 9.00 (+25.0%)	Re-rated 15.0% toward industry PE of 62.79 (still at or below it)	Rs 446	+43.8%

Each target takes today's price of Rs 310.25 and scales it by the EPS growth assumed for that case, which is the same as holding the PE multiple constant. The conservative case uses the lower of the FY26 EPS growth and the 4-year EPS CAGR, the base case uses their average and the bull case uses the higher figure. The bull case also re-rates the PE multiple toward the industry level, because the stock trades below it. Together they form the Artemis Medicare Services target price range for the FY27 outlook over the next 12 months, and the range is not a point estimate.

Artemis Medicare Services Share Price Forecast: What Has to Go Right by 2027

Each Artemis Medicare Services target price below depends on a specific EPS outcome, and the text states that outcome next to the number.

Conservative Case for the Artemis Medicare Services Share Price Target: Rs 357

Reaching Rs 357 needs EPS to rise 15.0% to Rs 8.28 while the stock keeps its current PE multiple. That follows the slower 4-year EPS CAGR of 30.1%.

Base Case for the Artemis Medicare Services Share Price Target: Rs 372

Reaching Rs 372 needs EPS to rise 20.0% to Rs 8.64, the average of the FY26 growth rate and the 4-year CAGR. Net profit growth of 48.3% in Q1 FY27 is at or above that pace, which supports the target.

Bull Case for the Artemis Medicare Services Share Price Target: Rs 446

Reaching Rs 446 needs EPS to rise 25.0% to Rs 9.00 and the PE multiple to re-rate 15.0% toward the industry PE. That is above the 52-week high of Rs 378.80, so it would need a fresh breakout. A daily close above the nearest resistance level of Rs 326.33 (50-day SMA) would be the first technical confirmation.

Artemis Medicare Services Financial Performance: Revenue, Profit and Margins

Artemis Medicare Services earned net profit of Rs 103.72 crore on revenue of Rs 1,111.07 crore in FY26, with profit up 26.2% and revenue up 14.6% compared with FY25. Diluted EPS was Rs 6.56 against Rs 5.31 a year earlier, and that earnings base anchors the Artemis Medicare Services share price forecast.

Year	Revenue (Rs Cr)	Net Profit (Rs Cr)	EPS (Rs)	Operating Margin	Net Margin
FY22	558.70	31.40	2.29	12.86%	5.62%
FY23	744.76	38.01	2.79	13.74%	5.10%
FY24	885.93	49.14	3.53	15.94%	5.55%
FY25	969.90	82.18	5.31	19.72%	8.47%
FY26	1,111.07	103.72	6.56	19.88%	9.34%

In the latest reported quarter, Q1 FY27 (quarter ended June 2026), revenue was Rs 292.69 crore against Rs 261.89 crore a year earlier (+11.8%), and the bottom line was a net profit of Rs 31.44 crore against a net profit of Rs 21.20 crore (+48.3%). Operating margin was 21.52% versus 18.95% in the year-ago quarter. Cash flow from operations was Rs 131.95 crore in FY26 against Rs 155.70 crore in FY25. Together these figures set the earnings base for the Artemis Medicare Services share price prediction.

Check the Univest Screener for live Artemis Medicare Services fundamentals

Is Artemis Medicare Services Overvalued or Undervalued Right Now?

Artemis Medicare Services trades at a PE of 42.84 against an industry PE of 62.79, which places the stock at a 31.8% discount to the industry average. The price-to-book ratio is 5.64 on a book value of Rs 54.69 per share. Return on equity of 11.09% means the company earns Rs 11.09 of profit for every Rs 100 of shareholder equity.

Debt to equity is 0.28, so borrowings equal about 28% of shareholder equity. The company declared a dividend of Rs 0.45 per share for FY26, a yield of 0.15% at the current price. This valuation context frames the Artemis Medicare Services stock price prediction for 2027 without relying on any outside forecast.

Artemis Medicare Services Stock Analysis: Technical Outlook

Artemis Medicare Services stock trades below its 50-day SMA of Rs 326.33 and above its 200-day EMA of Rs 282.93, and the combined daily indicators read bearish. The 52-week high of Rs 378.80 was set on 25 September 2026, while the 52-week low of Rs 203.35 came on 30 March 2026.

Indicator	Reading	Signal
RSI (14)	36.73	Weak momentum
MACD (12,26,9)	-2.32 vs signal 3.26	Bearish
ADX (14)	16.74	Weak trend
Supertrend (10,3)	Price below Rs 366.16	Bearish
50-day SMA	Rs 326.33	Price below
200-day EMA	Rs 282.93	Price above

The nearest support level sits at Rs 282.93 (200-day EMA) and Rs 203.35 (52-week low). The nearest resistance level sits at Rs 326.33 (50-day SMA) and Rs 366.16 (Supertrend). A sustained move above the nearest resistance would support the Artemis Medicare Services share price prediction 2027 base case, and this Artemis Medicare Services stock analysis uses daily candles only. Chart signals add context to the Artemis Medicare Services share price target without changing the earnings maths.

Artemis Medicare Services Shareholding Pattern

Promoters hold 58.39% of Artemis Medicare Services as of Jun 2026, down from 66.53% in Sep 2025 across the last 5 quarters. FII holding is 12.29% (up from 0.37% in Sep 2025) and DII holding is 2.40% (down from 4.27% in Sep 2025), which puts combined institutional holding at 14.69%. Public shareholders own 26.92%. Shareholding data is one input for any Artemis Medicare Services stock forecast. Ownership is a useful cross-check on any Artemis Medicare Services share price prediction.

Key Risks to the Artemis Medicare Services Share Price Target for 2027

Earnings and Margin Risk

Operating margin has ranged from 12.86% to 19.88% between FY22 and FY26, so a slip toward the lower end would trim the EPS estimate behind the Artemis Medicare Services stock forecast. Revenue was up 14.6% in FY26, and slower revenue growth would weigh on the profit path.

Size and Liquidity Risk

Market capitalisation stands at Rs 4,883 crore. Investors should check daily traded volumes and order book depth on NSE before sizing a position, because price moves can be sharper when volumes thin out. Liquidity is a practical constraint on any Artemis Medicare Services stock price target.

Balance Sheet Risk

Debt to equity of 0.28 means borrowings stand at about 28% of shareholder equity. A rise in borrowing costs or a jump in debt would weigh on profit and on the multiple behind the Artemis Medicare Services share price forecast.

Technical Risk

The daily indicators read bearish, so the targets above may need a technical turn before the price follows earnings. A daily close below Rs 282.93 (200-day EMA) would weaken the setup further.

Conclusion

This Artemis Medicare Services stock analysis puts the share price target range for 2027 at Rs 357 to Rs 446, with a base case of Rs 372 against Rs 310.25 today. The inputs are a PE of 42.84 that sits at a 31.8% discount to the industry average, EPS growth of 23.5% in FY26 and a daily technical setup that reads bearish. The next quarterly result will show which scenario is gaining ground. This analysis is educational, so consult a SEBI-registered advisor before acting on it.

Download the Univest iOS App or Univest Android App to track Artemis Medicare Services live price and get daily stock recommendations.

Frequently Asked Questions on Artemis Medicare Services Share Price Prediction 2027

What is the Artemis Medicare Services share price target for 2027?

Ans. The Artemis Medicare Services share price forecast for 2027 has a conservative case of Rs 357, a base case of Rs 372 and a bull case of Rs 446. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.

What is the Artemis Medicare Services share price today?

Ans. Artemis Medicare Services trades at Rs 310.25 on NSE as of 9 October 2026, up 0.58% on the day. The 52-week range is Rs 203.35 to Rs 378.80.

Is Artemis Medicare Services a good stock to buy for 2027?

Ans. The data points in different directions: the PE of 42.84 is at a 31.8% discount to the industry average, EPS grew 23.5% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.

Can Artemis Medicare Services stock reach Rs 446 in 2027?

Ans. Reaching Rs 446 needs EPS to rise 25.0% from Rs 7.20 and the PE multiple to re-rate toward the industry PE of 62.79, plus a daily close above Rs 326.33 (50-day SMA). This is a scenario, not a guarantee.

What are the support and resistance levels for Artemis Medicare Services?

Ans. The nearest support levels are Rs 282.93 (200-day EMA) and Rs 203.35 (52-week low), and the nearest resistance levels are Rs 326.33 (50-day SMA) and Rs 366.16 (Supertrend).

What are the main risks for Artemis Medicare Services stock in 2027?

Ans. The main risks to the Artemis Medicare Services share price forecast are a fall in operating margin from the 12.86% to 19.88% range seen since FY22, slower revenue growth after FY26 revenue was up 14.6%, and thin trading volumes. Debt to equity of 0.28 adds balance sheet sensitivity.

How is the Artemis Medicare Services target price for 2027 calculated?

Ans. Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 15.0% growth, the base case 20.0% and the bull case 25.0%, all drawn from the company's reported FY26 and 4-year EPS growth.